Clinical Trials Browser

Phase 3 × Neurofibroma, Plexiform × 30 days × Clear all

NCT07407803 2026-05-27

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

Phase 3 Recruiting

Neurofibroma, Plexiform